Alzheimer's disease & dementia

'Remarkable' Alzheimer's drug reduces cognitive decline, study shows

US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing ...

Alzheimer's disease & dementia

New insights into eye damage in Alzheimer's disease patients

Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond ...

Medical research

Alzheimer's study links cholesterol and toxic protein clusters

Cholesterol tremendously increases the toxicity of a peptide implicated in Alzheimer's progression, according to research by scientists in the Department of Biochemistry and Biophysics in Texas A&M's College of Agriculture ...

page 5 from 37